---
title: "Autobio: Net profit in the first half of 2025 is 571 million yuan, a year-on-year decrease of 7.83%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253950249.md"
description: "Autobio announced that its operating revenue in the first half of 2025 was 2.06 billion yuan, a year-on-year decrease of 6.65%. Net profit was 571 million yuan, a year-on-year decrease of 7.83%"
datetime: "2025-08-21T09:01:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253950249.md)
  - [en](https://longbridge.com/en/news/253950249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253950249.md)
---

# Autobio: Net profit in the first half of 2025 is 571 million yuan, a year-on-year decrease of 7.83%

Autobio announced that its operating revenue in the first half of 2025 was 2.06 billion yuan, a year-on-year decrease of 6.65%. Net profit was 571 million yuan, a year-on-year decrease of 7.83%

### Related Stocks

- [603658.CN](https://longbridge.com/en/quote/603658.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [10:45 ETInventHelp Inventor Develops New Illuminated Display (SGM-649)](https://longbridge.com/en/news/286933598.md)
- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)
- [BCAL Diagnostics Expands National Access to Early Cancer Detection Blood Tests](https://longbridge.com/en/news/286850851.md)
- [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md)